US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Serina Therapeutics, Inc.

2.57

+0.07002.80%

Pre-market: 2.730.1600+6.23%06:00 EDT

Volume:404.46K

Turnover:1.05M

Market Cap:65.28M

PE:-1.33

High:2.78

Open:2.75

Low:2.35

Close:2.50

52wk High:5.83

52wk Low:1.22

Shares:25.40M

Float Shares:11.48M

Volume Ratio:11.26

T/O Rate:3.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9304

EPS(LYR):-1.9100

ROE:-207.94%

ROA:-92.30%

PB:3.49

PE(LYR):-1.35

Loading ...

Overview Company News Filings

Serina Therapeutics Director Stephen K. Brannan Acquires 1,000 Common Shares Worth $2,030

Seres Therapeutics' Phase 1 Trial of SER-155 Meets Primary Endpoint; Shares Rise Pre-Bell

MT Newswires Live

Seres Therapeutics announces top-line results from SER-155 trial

Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment

Sumitomo Backs $1m Exploration Push at SER’s Bulimba Gold Project

Serina Therapeutics initiated with a Buy at BTIG

Gannet Biochem and Serina Therapeutics Enter Development Partnership Supporting Ser-252 Program

THOMSON REUTERS

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

Serina Therapeutics Shareholders Approved Increase in Authorized Common Shares to 125 Million

Serina Therapeutics director Jay Venkatesan acquires 589 common shares valued at $1,048.42

Serina Therapeutics director Karen J. Wilson acquires common shares worth $17,894.50

Serina Therapeutics director Karen J. Wilson acquires USD 37,000 common shares

Serina Therapeutics director Richard Peter Marshall buys USD 20,102 common shares

Serina Therapeutics files to sell 16.45M shares of common stock for holders

Serina Therapeutics Inc - Files to Register Resale of up to 16.5 Mln Common Shares by Selling Stockholder- SEC Filing

THOMSON REUTERS

Serina Therapeutics (SER) Gets a Buy from JonesTrading

Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks

Serina Therapeutics: Q1 EPS $-0.58

THOMSON REUTERS

Serina Therapeutics: Ser-252 Phase 1B Registrational Study Underway in Advanced Parkinson's Disease; Tfl Data Targeted for H1 2027

THOMSON REUTERS

Serina Therapeutics Q1 FY26 net loss widens to $6.9 million from Q1 FY25

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/SER/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SER","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SER\",,,,,undefined,":{"symbol":"SER","market":"US","secType":"STK","nameCN":"Serina Therapeutics, Inc.","latestPrice":2.57,"timestamp":1788984000000,"preClose":2.5,"halted":0,"volume":404459,"hourTrading":{"tag":"盘前","latestPrice":2.73,"preClose":2.57,"latestTime":"06:00 EDT","volume":29,"amount":76.9699962,"timestamp":1789034420142,"change":0.16,"changeRate":0.062257,"amplitude":0.140078},"delay":0,"changeRate":0.027999999999999935,"floatShares":11482448,"shares":25400500,"eps":-1.93037,"marketStatus":"Pre-Mkt","change":0.07,"latestTime":"09-10 06:12:05 EDT","open":2.75,"high":2.78,"low":2.35,"amount":1045363.2753476001,"amplitude":0.172,"askPrice":2.95,"askSize":5,"bidPrice":1.83,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.93037,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"exchange":"AMEX","adjPreClose":2.57,"preHourTrading":{"tag":"盘前","latestPrice":2.73,"preClose":2.57,"latestTime":"06:00 EDT","volume":29,"amount":76.9699962,"timestamp":1789034420142,"change":0.16,"changeRate":0.062257,"amplitude":0.140078},"postHourTrading":{"tag":"盘后","latestPrice":2.56,"preClose":2.57,"latestTime":"19:59 EDT","volume":1686,"amount":4222.1695,"timestamp":1788998375290,"change":-0.01,"changeRate":-0.003891,"amplitude":0.038911},"volumeRatio":11.257173873822586},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SER\",,,,,undefined,":{"symbol":"SER","floatShares":11482448,"roa":"-92.30%","roe":"-207.94%","lyrEps":-1.91,"volumeRatio":11.257173873822586,"shares":25400500,"dividePrice":0,"high":2.78,"amplitude":0.172,"preClose":2.5,"low":2.35,"week52Low":1.22,"pbRate":"3.49","week52High":5.83,"institutionHeld":0,"latestPrice":2.57,"committee":0.904762,"eps":-1.93037,"divideRate":0,"volume":404459,"delay":0,"ttmEps":-1.93037,"open":2.75,"prevYearClose":1.913,"prevWeekClose":2.73,"prevMonthClose":2.42,"prevQuarterClose":1.94,"fiveDayClose":2.5,"twentyDayClose":2.78,"sixtyDayClose":1.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SER\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"SER","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.55},{"market":"US","date":"2026-05-14","symbol":"SER","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2026-03-25","symbol":"SER","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-11-13","symbol":"SER","fiscalQuarterEnding":"2025/09","expectedEps":-0.47,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-08-11","symbol":"SER","fiscalQuarterEnding":"2025/06","expectedEps":-0.36,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SER\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SER\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1782964800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SER\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SER","date":"2026-09-09","current":-1.331351,"percent":0.615514,"low":-65.600015,"twenty":-9.511179,"median":-4.329002,"eighty":-1.339149,"high":37.356482,"avg":-9.268678,"sd":18.949885,"marketCap":63501182},"quantilePoints":[{"date":"2024-04-05","current":29.141387,"twenty":30.584579,"median":32.083279,"eighty":33.732959,"marketCap":105541506},{"date":"2024-04-12","current":17.770243,"twenty":17.783016,"median":23.543628,"eighty":32.232039,"marketCap":93646584},{"date":"2024-04-19","current":17.456349,"twenty":17.731924,"median":17.945869,"eighty":31.172957,"marketCap":91992413},{"date":"2024-04-26","current":14.673941,"twenty":16.787882,"median":17.778226,"eighty":29.502185,"marketCap":77329529},{"date":"2024-05-03","current":14.209648,"twenty":14.673941,"median":17.57865,"eighty":21.283439,"marketCap":74882770},{"date":"2024-05-10","current":14.050147,"twenty":14.209648,"median":17.078432,"eighty":18.800885,"marketCap":74042223},{"date":"2024-05-17","current":12.820759,"twenty":14.187327,"median":15.966076,"eighty":18.090969,"marketCap":67563528},{"date":"2024-05-24","current":15.167772,"twenty":14.187327,"median":15.718602,"eighty":17.818141,"marketCap":79931945},{"date":"2024-05-31","current":-13.721878,"twenty":13.545619,"median":15.079879,"eighty":17.786209,"marketCap":79931945},{"date":"2024-06-07","current":-14.08298,"twenty":12.926135,"median":14.744671,"eighty":17.776629,"marketCap":82035417},{"date":"2024-06-14","current":-14.564515,"twenty":-13.557216,"median":14.673941,"eighty":17.770243,"marketCap":84840426},{"date":"2024-06-21","current":-15.922863,"twenty":-13.825876,"median":14.209648,"eighty":17.731924,"marketCap":92753004},{"date":"2024-06-28","current":-12.919404,"twenty":-13.944317,"median":14.209648,"eighty":17.655287,"marketCap":75257414},{"date":"2024-07-05","current":-11.364849,"twenty":-13.990538,"median":14.209648,"eighty":17.52973,"marketCap":66201907},{"date":"2024-07-12","current":-11.153551,"twenty":-13.799876,"median":13.810656,"eighty":17.339222,"marketCap":64971062},{"date":"2024-07-15","current":-13.477836,"twenty":-13.773877,"median":13.571165,"eighty":17.280659,"marketCap":78510363},{"date":"2024-08-02","current":-12.964682,"twenty":-13.747877,"median":13.539233,"eighty":17.222095,"marketCap":75521166},{"date":"2024-08-09","current":-11.364095,"twenty":-13.723872,"median":13.251843,"eighty":17.027373,"marketCap":66197511},{"date":"2024-08-16","current":-8.441425,"twenty":-13.721878,"median":2.384851,"eighty":16.171527,"marketCap":59150297},{"date":"2024-08-23","current":-10.330099,"twenty":-13.617881,"median":-8.582039,"eighty":15.966076,"marketCap":72384510},{"date":"2024-08-30","current":-10.13985,"twenty":-13.52255,"median":-9.00413,"eighty":15.966076,"marketCap":71051408},{"date":"2024-09-06","current":-10.104487,"twenty":-13.488788,"median":-9.975078,"eighty":15.85112,"marketCap":70803616},{"date":"2024-09-13","current":-7.831133,"twenty":-13.268937,"median":-9.379361,"eighty":15.707426,"marketCap":54873890},{"date":"2024-09-20","current":-7.554188,"twenty":-13.112179,"median":-8.839249,"eighty":15.365752,"marketCap":52933298},{"date":"2024-09-27","current":-9.43006,"twenty":-13.019016,"median":-9.049816,"eighty":15.0623,"marketCap":66077809},{"date":"2024-10-04","current":-8.251303,"twenty":-12.937515,"median":-8.845695,"eighty":14.905865,"marketCap":57818083},{"date":"2024-10-11","current":-8.580848,"twenty":-12.554189,"median":-8.732946,"eighty":14.786183,"marketCap":60127254},{"date":"2024-10-18","current":-9.769745,"twenty":-12.214089,"median":-8.764633,"eighty":14.702233,"marketCap":68458031},{"date":"2024-10-25","current":-8.872369,"twenty":-11.941393,"median":-8.872369,"eighty":14.673941,"marketCap":62169982},{"date":"2024-10-31","current":-8.568173,"twenty":-11.747964,"median":-8.847019,"eighty":14.628789,"marketCap":60038439},{"date":"2024-11-08","current":-5.742165,"twenty":-11.5456,"median":-8.764633,"eighty":14.420496,"marketCap":40236191},{"date":"2024-11-15","current":-6.048407,"twenty":-11.364849,"median":-8.720054,"eighty":14.209648,"marketCap":44459880},{"date":"2024-11-22","current":-5.928673,"twenty":-11.364547,"median":-8.695365,"eighty":14.209648,"marketCap":43570682},{"date":"2024-11-29","current":-6.352149,"twenty":-11.321986,"median":-8.600455,"eighty":14.209648,"marketCap":46682874},{"date":"2024-12-06","current":-7.456945,"twenty":-11.110513,"median":-8.568173,"eighty":14.187327,"marketCap":54802179},{"date":"2024-12-13","current":-6.006451,"twenty":-10.914992,"median":-8.561836,"eighty":14.088465,"marketCap":44142287},{"date":"2024-12-20","current":-7.07266,"twenty":-10.789111,"median":-8.479449,"eighty":13.954351,"marketCap":51978012},{"date":"2024-12-27","current":-6.747673,"twenty":-10.659517,"median":-8.390726,"eighty":13.571165,"marketCap":49589633},{"date":"2025-01-03","current":-6.517639,"twenty":-10.562175,"median":-8.162579,"eighty":13.520073,"marketCap":47899077},{"date":"2025-01-10","current":-5.904214,"twenty":-10.499761,"median":-8.051056,"eighty":13.363605,"marketCap":43390929},{"date":"2025-01-17","current":-6.07035,"twenty":-10.463782,"median":-7.83254,"eighty":13.258229,"marketCap":44611886},{"date":"2025-01-24","current":-6.006451,"twenty":-10.451708,"median":-7.712623,"eighty":13.14966,"marketCap":44142287},{"date":"2025-01-31","current":-5.878654,"twenty":-10.421318,"median":-7.617562,"eighty":12.926135,"marketCap":43203089},{"date":"2025-02-07","current":-5.878654,"twenty":-10.364245,"median":-7.402632,"eighty":5.571028,"marketCap":43203089},{"date":"2025-02-14","current":-5.955332,"twenty":-10.299629,"median":-7.207741,"eighty":-5.38422,"marketCap":43766608},{"date":"2025-02-21","current":-6.249265,"twenty":-10.231108,"median":-7.041606,"eighty":-5.510713,"marketCap":45926762},{"date":"2025-02-28","current":-6.380056,"twenty":-10.13985,"median":-6.713492,"eighty":-5.574659,"marketCap":46887966},{"date":"2025-03-07","current":-6.326216,"twenty":-10.13478,"median":-6.696682,"eighty":-5.743169,"marketCap":46492287},{"date":"2025-03-14","current":-5.532074,"twenty":-10.112497,"median":-6.684888,"eighty":-5.743169,"marketCap":40656021},{"date":"2025-03-21","current":-6.110856,"twenty":-10.104487,"median":-6.616553,"eighty":-5.743169,"marketCap":44909571},{"date":"2025-03-28","current":-4.234631,"twenty":-10.098885,"median":-6.511249,"eighty":-5.532216,"marketCap":47178021},{"date":"2025-04-04","current":-4.894342,"twenty":-10.073941,"median":-6.460817,"eighty":-4.926436,"marketCap":54527860},{"date":"2025-04-11","current":-4.279206,"twenty":-10.051126,"median":-6.404799,"eighty":-4.716041,"marketCap":47674632},{"date":"2025-04-17","current":-4.680381,"twenty":-10.000427,"median":-6.391338,"eighty":-4.680381,"marketCap":52144128},{"date":"2025-04-25","current":-5.429242,"twenty":-9.949728,"median":-6.352149,"eighty":-4.680381,"marketCap":60487189},{"date":"2025-05-02","current":-4.733871,"twenty":-9.769745,"median":-6.319486,"eighty":-4.680381,"marketCap":52740061},{"date":"2025-05-09","current":-5.121942,"twenty":-9.696231,"median":-6.287604,"eighty":-4.698211,"marketCap":57063554},{"date":"2025-05-16","current":-59.867974,"twenty":-10.063801,"median":-6.319486,"eighty":-4.716041,"marketCap":56216028},{"date":"2025-05-23","current":-62.521698,"twenty":-10.1145,"median":-6.352149,"eighty":-4.716041,"marketCap":58707874},{"date":"2025-05-30","current":-61.035612,"twenty":-10.269158,"median":-6.380056,"eighty":-4.730305,"marketCap":57312440},{"date":"2025-06-06","current":-63.15859,"twenty":-10.460251,"median":-6.404799,"eighty":-4.739577,"marketCap":59305916},{"date":"2025-06-13","current":-62.893218,"twenty":-10.844881,"median":-6.460817,"eighty":-4.756693,"marketCap":59056732},{"date":"2025-06-20","current":-61.035612,"twenty":-11.364397,"median":-6.504859,"eighty":-4.787361,"marketCap":57312440},{"date":"2025-06-27","current":-65.069271,"twenty":-11.941393,"median":-6.601297,"eighty":-4.858682,"marketCap":61100045},{"date":"2025-07-03","current":-63.052442,"twenty":-12.946571,"median":-6.683774,"eighty":-4.897908,"marketCap":59206243},{"date":"2025-07-11","current":-62.585387,"twenty":-13.494265,"median":-6.687561,"eighty":-4.963879,"marketCap":58767678},{"date":"2025-07-18","current":-56.365062,"twenty":-13.727859,"median":-6.706215,"eighty":-5.054812,"marketCap":52926793},{"date":"2025-07-25","current":-57.320401,"twenty":-14.163867,"median":-6.747673,"eighty":-5.06551,"marketCap":53823857},{"date":"2025-08-01","current":-58.806486,"twenty":-14.540367,"median":-7.140201,"eighty":-5.097711,"marketCap":55219290},{"date":"2025-08-08","current":-57.851146,"twenty":-16.339423,"median":-7.348318,"eighty":-5.123618,"marketCap":54322226},{"date":"2025-08-15","current":-4.477661,"twenty":-17.151414,"median":-7.290809,"eighty":-5.06551,"marketCap":56378234},{"date":"2025-08-22","current":-4.477661,"twenty":-16.339423,"median":-7.07266,"eighty":-4.840851,"marketCap":56378234},{"date":"2025-08-29","current":-4.176437,"twenty":-15.621008,"median":-6.732661,"eighty":-4.723173,"marketCap":52585516},{"date":"2025-09-05","current":-4.298555,"twenty":-15.168225,"median":-6.706215,"eighty":-4.683947,"marketCap":54123104},{"date":"2025-09-12","current":-4.152013,"twenty":-15.047483,"median":-6.687561,"eighty":-4.603418,"marketCap":52277998},{"date":"2025-09-19","current":-3.671682,"twenty":-14.552441,"median":-6.683774,"eighty":-4.480762,"marketCap":46230151},{"date":"2025-09-26","current":-4.054319,"twenty":-14.495088,"median":-6.586042,"eighty":-4.445795,"marketCap":51047928},{"date":"2025-10-03","current":-4.274131,"twenty":-14.455909,"median":-6.482838,"eighty":-4.363684,"marketCap":53815587},{"date":"2025-10-10","current":-4.670023,"twenty":-14.397862,"median":-6.433897,"eighty":-4.347636,"marketCap":58800259},{"date":"2025-10-17","current":-4.092547,"twenty":-14.188422,"median":-6.402621,"eighty":-4.323139,"marketCap":51529260},{"date":"2025-10-24","current":-4.322701,"twenty":-14.088758,"median":-6.364249,"eighty":-4.310147,"marketCap":54427122},{"date":"2025-10-31","current":-4.008855,"twenty":-14.036759,"median":-6.339182,"eighty":-4.297619,"marketCap":50475491},{"date":"2025-11-07","current":-3.448117,"twenty":-13.827869,"median":-6.299296,"eighty":-4.264361,"marketCap":43415245},{"date":"2025-11-14","current":-3.280733,"twenty":-13.729853,"median":-6.273601,"eighty":-4.236343,"marketCap":41307709},{"date":"2025-11-21","current":-2.15737,"twenty":-13.721878,"median":-6.249265,"eighty":-4.197811,"marketCap":40096880},{"date":"2025-11-28","current":-2.444254,"twenty":-13.721878,"median":-6.245456,"eighty":-4.152013,"marketCap":45428912},{"date":"2025-12-05","current":-1.990977,"twenty":-13.591882,"median":-6.147028,"eighty":-4.102049,"marketCap":37004302},{"date":"2025-12-12","current":-1.801633,"twenty":-13.505217,"median":-6.121468,"eighty":-4.090954,"marketCap":33485160},{"date":"2025-12-19","current":-1.524503,"twenty":-13.477836,"median":-6.11051,"eighty":-4.06246,"marketCap":28334418},{"date":"2025-12-26","current":-1.399995,"twenty":-13.199304,"median":-6.089519,"eighty":-4.041726,"marketCap":26020316},{"date":"2026-01-02","current":-1.097619,"twenty":-13.112179,"median":-6.083129,"eighty":-3.997732,"marketCap":20400354},{"date":"2026-01-09","current":-1.503274,"twenty":-13.019016,"median":-6.07035,"eighty":-3.774262,"marketCap":27939847},{"date":"2026-01-16","current":-1.543438,"twenty":-12.937515,"median":-6.048407,"eighty":-3.438074,"marketCap":28686332},{"date":"2026-01-23","current":-1.698355,"twenty":-12.675928,"median":-6.046598,"eighty":-3.349361,"marketCap":31565629},{"date":"2026-01-30","current":-2.031141,"twenty":-12.246297,"median":-6.019231,"eighty":-2.444254,"marketCap":37750786},{"date":"2026-02-06","current":-1.433355,"twenty":-12.01082,"median":-6.006451,"eighty":-2.225304,"marketCap":26640343},{"date":"2026-02-13","current":-0.98652,"twenty":-11.747964,"median":-6.006451,"eighty":-2.15737,"marketCap":18335458},{"date":"2026-02-20","current":-1.003929,"twenty":-11.605851,"median":-5.962795,"eighty":-2.0036,"marketCap":18659025},{"date":"2026-02-27","current":-1.050353,"twenty":-11.364849,"median":-5.922833,"eighty":-1.871633,"marketCap":19521870},{"date":"2026-03-06","current":-0.91108,"twenty":-11.364698,"median":-5.904214,"eighty":-1.792453,"marketCap":16933335},{"date":"2026-03-13","current":-0.905277,"twenty":-11.321986,"median":-5.880344,"eighty":-1.689175,"marketCap":16825479},{"date":"2026-03-20","current":-1.439158,"twenty":-11.110513,"median":-5.878654,"eighty":-1.646716,"marketCap":26748198},{"date":"2026-03-27","current":-1.467538,"twenty":-10.914992,"median":-5.860708,"eighty":-1.608363,"marketCap":28150322},{"date":"2026-04-02","current":-1.360964,"twenty":-10.82151,"median":-5.792072,"eighty":-1.560651,"marketCap":26106017},{"date":"2026-04-10","current":-1.283929,"twenty":-10.659517,"median":-5.747183,"eighty":-1.531962,"marketCap":24628318},{"date":"2026-04-17","current":-1.277509,"twenty":-10.537839,"median":-5.619103,"eighty":-1.503274,"marketCap":24505176},{"date":"2026-04-24","current":-1.245411,"twenty":-10.474376,"median":-5.532074,"eighty":-1.457259,"marketCap":23889468},{"date":"2026-05-01","current":-1.168375,"twenty":-10.45672,"median":-5.366406,"eighty":-1.411471,"marketCap":22411769},{"date":"2026-05-08","current":-1.405823,"twenty":-10.444191,"median":-5.170707,"eighty":-1.405823,"marketCap":26966496},{"date":"2026-05-15","current":-1.33592,"twenty":-10.387009,"median":-5.152877,"eighty":-1.38852,"marketCap":25625621},{"date":"2026-05-22","current":-1.32194,"twenty":-10.330099,"median":-5.121942,"eighty":-1.360964,"marketCap":28113690},{"date":"2026-05-29","current":-1.366074,"twenty":-10.269158,"median":-5.054812,"eighty":-1.357002,"marketCap":29052303},{"date":"2026-06-05","current":-1.303025,"twenty":-10.162665,"median":-4.898799,"eighty":-1.332617,"marketCap":27711427},{"date":"2026-06-12","current":-1.267997,"twenty":-10.13985,"median":-4.760616,"eighty":-1.316834,"marketCap":26966496},{"date":"2026-06-18","current":-1.387091,"twenty":-10.12464,"median":-4.733871,"eighty":-1.316632,"marketCap":29499261},{"date":"2026-06-26","current":-1.283465,"twenty":-10.108492,"median":-4.713955,"eighty":-1.313459,"marketCap":27295459},{"date":"2026-07-02","current":-1.353985,"twenty":-10.104487,"median":-4.689296,"eighty":-1.312175,"marketCap":28795209},{"date":"2026-07-10","current":-1.551442,"twenty":-10.093283,"median":-4.680381,"eighty":-1.316431,"marketCap":32994511},{"date":"2026-07-17","current":-1.396298,"twenty":-10.071406,"median":-4.608878,"eighty":-1.318089,"marketCap":29695059},{"date":"2026-07-24","current":-1.47387,"twenty":-10.038451,"median":-4.546656,"eighty":-1.320577,"marketCap":31344785},{"date":"2026-07-31","current":-1.43861,"twenty":-9.990287,"median":-4.493166,"eighty":-1.323761,"marketCap":30594910},{"date":"2026-08-07","current":-1.657222,"twenty":-9.913731,"median":-4.473591,"eighty":-1.331403,"marketCap":35244136},{"date":"2026-08-14","current":-2.009822,"twenty":-9.755042,"median":-4.445096,"eighty":-1.33332,"marketCap":42742889},{"date":"2026-08-21","current":-3.178808,"twenty":-9.673416,"median":-4.399188,"eighty":-1.335413,"marketCap":67311253},{"date":"2026-08-28","current":-3.022866,"twenty":-9.569483,"median":-4.363684,"eighty":-1.336346,"marketCap":64009191},{"date":"2026-09-04","current":-3.22679,"twenty":-9.516249,"median":-4.337372,"eighty":-1.338418,"marketCap":68327272},{"date":"2026-09-09","current":-2.998875,"twenty":-9.511179,"median":-4.329002,"eighty":-1.339149,"marketCap":63501182}],"updateTime":1789035125908},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SER\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2650097580","title":"Serina Therapeutics Director Stephen K. Brannan Acquires 1,000 Common Shares Worth $2,030","url":"https://stock-news.laohu8.com/highlight/detail?id=2650097580","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650097580?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:05","pubTimestamp":1783613143,"startTime":"0","endTime":"0","summary":"Serina Therapeutics director Stephen K. Brannan acquires 1,000 common shares worth $2,030Serina Therapeutics director Stephen K. Brannan bought 1,000 common shares at USD 2.03 each.Brannan’s direct ho","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL9n3KT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Serina Therapeutics Director Stephen K. Brannan Acquires 1,000 Common Shares Worth $2,030","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649699345","title":"Seres Therapeutics' Phase 1 Trial of SER-155 Meets Primary Endpoint; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2649699345","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649699345?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:55","pubTimestamp":1783511748,"startTime":"0","endTime":"0","summary":"Seres Therapeutics  said Wednesday that top-line results from a phase 1 clinical trial of SER-155 to treat patients with immune checkpoint inhibitor-related enterocolitis met its primary endpoint.The primary endpoint was defined as at least a 1-grade improvement in diarrhea symptoms without immunosuppressive therapy, such as a corticosteroid and/or a biologic immunomodulator drug.Inhibitor-related enterocolitis, or irEC, is a frequent side effect of immune checkpoint inhibitors that often causes patients to halt cancer treatment.\"Patients receiving ICI treatment who develop irEC face significant challenges, as current management often necessitates interruption or discontinuation of checkpoint inhibitor therapy and treatment with systemic immunosuppressives, which are associated with clinically significant side effects,\" Principal Investigator David Faleck said in a statement.Shares of Seres Therapeutics were up more than 6% pre-bell.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","MCRB","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649099825","title":"Seres Therapeutics announces top-line results from SER-155 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2649099825","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649099825?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:20","pubTimestamp":1783509616,"startTime":"0","endTime":"0","summary":"Seres Therapeutics (MCRB) announced top-line results from an investigator-sponsored trial evaluating SER-155 in patients with irEC. The study, cond...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seres-therapeutics-announces-top-line-results-from-ser-155-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seres-therapeutics-announces-top-line-results-from-ser-155-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MCRB","BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649896003","title":"Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2649896003","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649896003?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:00","pubTimestamp":1783508400,"startTime":"0","endTime":"0","summary":"80% of SER-155 recipients achieved immunosuppressive-free clinical response of diarrhea (a primary symptom of irEC) at Day 15 in the Investigator-Sponsored Trial (IST) conducted by Memorial Sloan Kett","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3323958/0/en/Seres-Therapeutics-Announces-Early-Clinical-Data-Showing-Potential-for-SER-155-in-Immune-Checkpoint-Inhibitor-Related-Enterocolitis-irEC-a-Frequent-Adverse-Reaction-That-Forces-Man.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCRB","BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648208815","title":"Sumitomo Backs $1m Exploration Push at SER’s Bulimba Gold Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2648208815","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648208815?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:35","pubTimestamp":1782952542,"startTime":"0","endTime":"0","summary":"Strategic Energy Resources Limited ( ($AU:SER) ) just unveiled an announcement. Strategic Energy Resources has secured approval from joint venture ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sumitomo-backs-1m-exploration-push-at-sers-bulimba-gold-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sumitomo-backs-1m-exploration-push-at-sers-bulimba-gold-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648519017","title":"Serina Therapeutics initiated with a Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2648519017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648519017?lang=en_us&edition=fundamental","pubTime":"2026-07-01 17:30","pubTimestamp":1782898210,"startTime":"0","endTime":"0","summary":"BTIG analyst Thomas Shrader initiated coverage of Serina Therapeutics (SER) with a Buy rating and $8 price target Serina is a clinical stage biotec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SER","LENZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647559558","title":"Gannet Biochem and Serina Therapeutics Enter Development Partnership Supporting Ser-252 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2647559558","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647559558?lang=en_us&edition=fundamental","pubTime":"2026-06-30 21:04","pubTimestamp":1782824691,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN432107:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646872350","title":"Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2646872350","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646872350?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:00","pubTimestamp":1782385200,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., June  25, 2026  (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that it will host a webcast to discuss top-line r","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/25/3317409/0/en/Seres-Therapeutics-to-Host-Webcast-on-July-8-2026-to-Discuss-Results-of-Investigator-Sponsored-Trial-of-Seres-SER-155-in-Immune-Checkpoint-Inhibitor-Related-Enterocolitis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","BK4139","SER","BK4588","BK4181","HST","BK4585","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646984554","title":"Serina Therapeutics Shareholders Approved Increase in Authorized Common Shares to 125 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2646984554","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646984554?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:11","pubTimestamp":1782331868,"startTime":"0","endTime":"0","summary":"Serina Therapeutics shareholders approved increase in authorized common shares to 125 millionSerina Therapeutics held its annual shareholder meeting on June 17, 2026.Shareholders backed an increase in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL7CNHcW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645005560","title":"Serina Therapeutics director Jay Venkatesan acquires 589 common shares valued at $1,048.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2645005560","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645005560?lang=en_us&edition=fundamental","pubTime":"2026-06-23 07:15","pubTimestamp":1782170133,"startTime":"0","endTime":"0","summary":"Serina Therapeutics director Jay Venkatesan reported an increase in common stock ownership to 231,705 shares held indirectly through a legacy trust.The position rose through conversion into 224,152 common shares priced at USD 2.25.Venkatesan also purchased 589 common shares at USD 1.78, bringing direct holdings to 589 shares.Separately, he received stock options for 15,250 shares with an exercise price of USD 1.98.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the informa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL1d55mQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Serina Therapeutics director Jay Venkatesan acquires 589 common shares valued at $1,048.42","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643320149","title":"Serina Therapeutics director Karen J. Wilson acquires common shares worth $17,894.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2643320149","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643320149?lang=en_us&edition=fundamental","pubTime":"2026-06-15 22:32","pubTimestamp":1781533971,"startTime":"0","endTime":"0","summary":"Serina Therapeutics director Karen J. Wilson bought 10,100 common shares in open-market purchases at about USD 1.75 to USD 1.77 each.Wilson’s direct stake rose to 10,100 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL1ZZ4P1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Serina Therapeutics director Karen J. Wilson acquires common shares worth $17,894.50","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638540078","title":"Serina Therapeutics director Karen J. Wilson acquires USD 37,000 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2638540078","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638540078?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:27","pubTimestamp":1779827248,"startTime":"0","endTime":"0","summary":"Serina Therapeutics director Karen J. Wilson bought 20,000 common shares in open-market purchases priced at USD 1.77 to USD 1.93.Wilson’s direct holding rose to 20,000 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDLbPRCbM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Serina Therapeutics director Karen J. Wilson acquires USD 37,000 common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637342849","title":"Serina Therapeutics director Richard Peter Marshall buys USD 20,102 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2637342849","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637342849?lang=en_us&edition=fundamental","pubTime":"2026-05-23 05:00","pubTimestamp":1779483619,"startTime":"0","endTime":"0","summary":"The shares were purchased at a weighted average price of USD 1.65.Marshall’s direct holding rose to 12,183 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL6tkj05:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Serina Therapeutics director Richard Peter Marshall buys USD 20,102 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637445223","title":"Serina Therapeutics files to sell 16.45M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2637445223","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637445223?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:06","pubTimestamp":1779480380,"startTime":"0","endTime":"0","summary":"16:01 EDT Serina Therapeutics (SER) files to sell 16.45M shares of common stock for holders Published first on TheFly – the ultimate source for rea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-files-to-sell-16-45m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-files-to-sell-16-45m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SER","BK4139","BK4007","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637417533","title":"Serina Therapeutics Inc - Files to Register Resale of up to 16.5 Mln Common Shares by Selling Stockholder- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637417533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637417533?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:02","pubTimestamp":1779480126,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z163:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636407728","title":"Serina Therapeutics (SER) Gets a Buy from JonesTrading","url":"https://stock-news.laohu8.com/highlight/detail?id=2636407728","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636407728?lang=en_us&edition=fundamental","pubTime":"2026-05-18 23:55","pubTimestamp":1779119711,"startTime":"0","endTime":"0","summary":"In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Serina Therapeutics, with a price target of $11.00. According...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/serina-therapeutics-ser-gets-a-buy-from-jonestrading-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/serina-therapeutics-ser-gets-a-buy-from-jonestrading-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635578750","title":"Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2635578750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635578750?lang=en_us&edition=fundamental","pubTime":"2026-05-16 14:00","pubTimestamp":1778911257,"startTime":"0","endTime":"0","summary":"Serina Therapeutics, Inc. (SER) has disclosed a new risk, in the Share Price & Shareholder Rights category. The March 2026 PIPE involving director ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/insider-backed-pipe-deal-may-dilute-serina-therapeutics-shareholders-and-heighten-governance-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/insider-backed-pipe-deal-may-dilute-serina-therapeutics-shareholders-and-heighten-governance-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","PIPE","SER","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635721462","title":"Serina Therapeutics: Q1 EPS $-0.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2635721462","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635721462?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:20","pubTimestamp":1778790000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA7RCJ7T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635214527","title":"Serina Therapeutics:  Ser-252 Phase 1B Registrational Study Underway in Advanced Parkinson's Disease; Tfl Data Targeted for H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2635214527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635214527?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:20","pubTimestamp":1778790000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA7RCJ7T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723544","title":"Serina Therapeutics Q1 FY26 net loss widens to $6.9 million from Q1 FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723544","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723544?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789108,"startTime":"0","endTime":"0","summary":"Serina Therapeutics posted a net loss of USD 6.9 million for quarter ended March 31, 2026, widening from USD 4.82 million year earlier.Operating loss widened to USD 6.28 million as operating expenses rose to USD 6.28 million, led by research and development costs of USD 3.2 million.Other expense swung to USD 611,000 from other income of USD 1.04 million, driven by a non-cash loss tied to amendment of convertible notes in connection with March 2026 PIPE.Cash and cash equivalents totaled USD 24.5 million at March 31, 2026; net cash used in operating activities was USD 4.57 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL6Vhn6L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":62,"code":"91000000","status":"200"}]}}